← Back

Dr. Martens PLC

Dr. Martens plc designs, develops, sources, markets, sells, and distributes footwear. It sells its footwear under the Dr. Martens brand across Europe, the Middle East, Africa, the Americas, and Asia-Pacific. The company was founded in 1945 and is based in London, United Kingdom.

Price · split & dividend adjusted
News & notes moving DOCS.LSE
United Kingdom
DOCS.LSE▲

Dr. Martens Hires Talent from Marc Jacobs and Adidas

Dr. Martens is strengthening its global product team with two new hires: Isadora Versani, joining from Marc Jacobs as global product design director, and Nadia Svensson, joining from Adidas as global merchandising and product director. Both will start in November and report to chief brand officer Carla Murphy, who arrived in July 2025. The brand says the roles are new and represent a significant investment in talent as it shifts to a consumer-first model. Versani brings over 17 years of footwear design experience, including work for Rihanna and Serena Williams, while Svensson previously led outdoor and sportswear categories at Adidas in Shanghai. Dr. Martens says it remains on track with its strategic objectives for fiscal year 2027.
DOCS.LSE · Capital · Positive Dr. Martens makes a significant investment in talent, hiring two new global product directors as part of its consumer-first strategy.
Read original ↗
Artificial Intelligence▲

European Shares Subdued Amid Escalating Iran Tensions

European stocks were subdued on Wednesday as escalating Middle East tensions overshadowed upbeat earnings results from companies including ASML Holding and Richemont. The pan-European STOXX 600 was marginally lower at 641.80 after rising 0.2 percent on Tuesday, while the German DAX dipped 0.6 percent and the UK's FTSE 100 slid 0.2 percent. ASML Holding surged over 4 percent after the Dutch chip equipment supplier lifted its annual sales forecast for the second time this year due to surging AI spending. Swiss luxury group Richemont soared 5.7 percent after reporting better-than-expected quarterly sales, helped by booming demand for its jewelry business. Other notable movers included Dr. Martens rising 1.3 percent after backing its annual outlook, Hunting jumping 5 percent on solid first-half trading, and B&M European Value Retail slumping 4.5 percent on modest first-quarter sales growth.
About megatrends
Artificial Intelligence › AI Compute & Accelerator Silicon ▲Demand
Semiconductors › Wafer-Fab Equipment & Lithography ▲Demand
ASML.AS · Demand · Positive Lifted annual sales forecast for second time due to surging AI spending, shares surged over 4%.
BME.LSE · Demand · Negative Modest first-quarter sales growth reported, causing shares to slump 4.5%.
CFR.SW · Demand · Positive Better-than-expected quarterly sales driven by booming jewelry demand, shares soared 5.7%.
DOCS.LSE · Capital · Positive Backed its annual outlook, leading to a 1.3% rise.
HTG.LSE · Capital · Positive Solid first-half trading reported, driving shares up 5%.
Read original ↗
RTTNews·82dRead more →
DOCS.LSE▲

Dr. Martens Keeps Fiscal 2027 Guidance Unchanged

Dr. Martens said trading since the start of the current financial year has been in line with expectations and its outlook and guidance for fiscal 2027 are unchanged. The company noted it is on track with strategic objectives for the year, with its largest market, the USA, continuing to grow and wholesale particularly encouraging. Japan and South Korea, its largest Asian markets, are both performing well, while European markets are performing as expected against a challenging consumer backdrop.
DOCS.LSE · Demand · Positive Trading in line with expectations, USA growing, wholesale encouraging, Asia performing well.
Read original ↗
RTTNews·82dRead more →